Quality of Life of Ghanaian Chronic Myeloid Leukaemia Patients on Tyrosine Kinase Inhibitors

被引：0
作者：
Kuma, A. Benneh-Akwasi [1 ,2 ]
Amponsah, E. [3 ]
Kyeremeh, R. [3 ]
Olayemi, E. [1 ,2 ]
机构：
[1] Univ Ghana, Haematol, Accra, Ghana
[2] Korle Bu Teaching Hosp, Accra, Ghana
[3] Univ Ghana, Med Lab Sci, Accra, Ghana
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 181卷
关键词：
Chronic myeloid leukaemia; Ghana; Quality of Life; Tyrosine Kinase Inhibitor;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH18-PO-0
引用
收藏
页码：67 / 68
页数：2
相关论文
共 50 条
  • [41] Comparative efficacy and safety of tyrosine kinase inhibitors for chronic myeloid leukaemia: A systematic review and network meta-analysis
    Fachi, Mariana M.
    Tonin, Fernanda S.
    Leonart, Leticia P.
    Aguiar, Karina S.
    Lenzi, Luana
    Figueiredo, Bonald C.
    Fernandez-Llimos, Fernando
    Pontarolo, Roberto
    EUROPEAN JOURNAL OF CANCER, 2018, 104 : 9 - 20
  • [42] Efficacy of a medication management service in improving adherence to tyrosine kinase inhibitors and clinical outcomes of patients with chronic myeloid leukaemia: a randomised controlled trial
    Bee Kim Tan
    Siew Siang Chua
    Li-Chia Chen
    Kian Meng Chang
    Sharmini Balashanker
    Ping Chong Bee
    Supportive Care in Cancer, 2020, 28 : 3237 - 3247
  • [43] Severe adverse effects associated with tyrosine kinase inhibitors therapy in chronic myeloid Leukaemia - case reports and literature review
    Krstanoska, Frosina
    Bricman, Irena Umek
    Fikfak, Natasa
    Ceh, Marija
    Zupan, Irena Preloznik
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2011, 80 (05): : 413 - 421
  • [44] Tyrosine kinase inhibitors induced immune thrombocytopenia in chronic myeloid leukemia?
    Barak, Avital F.
    Bonstein, Lilach
    Lauterbach, Roy
    Naparstek, Elizabeth
    Tavor, Sigal
    HEMATOLOGY REPORTS, 2011, 3 (03) : 95 - 97
  • [45] WHO 2016 Definition of Chronic Myeloid Leukemia and Tyrosine Kinase Inhibitors
    Haznedaroglu, Ibrahim C.
    Kuzu, Isinsu
    Ilhan, Osman
    TURKISH JOURNAL OF HEMATOLOGY, 2020, 37 (01) : 42 - 47
  • [46] Adherence to tyrosine kinase inhibitors among adult chronic myeloid leukemia patients in a Malaysia hospital
    P. M. Lee
    C. T. Chang
    Z. M. Yusoff
    International Journal of Clinical Pharmacy, 2021, 43 : 46 - 54
  • [47] Adherence to tyrosine kinase inhibitors among adult chronic myeloid leukemia patients in a Malaysia hospital
    Lee, P. M.
    Chang, C. T.
    Yusoff, Z. M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (01) : 46 - 54
  • [48] Side effects and medication adherence of tyrosine kinase inhibitors for patients with chronic myeloid leukemia in Taiwan
    Tsai, Yu-Fen
    Huang, Wen-Chuan
    Cho, Shih-Feng
    Hsiao, Hui-Hua
    Liu, Yi-Chang
    Lin, Sheng-Fung
    Liu, Ta-Chih
    Chang, Chao-Sung
    MEDICINE, 2018, 97 (26)
  • [49] Definition and treatment of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia
    Baccarani, Michele
    Castagnetti, Fausto
    Gugliotta, Gabriele
    Palandri, Francesca
    Rosti, Gianantonio
    EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (03) : 397 - 406
  • [50] Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era
    Gunnarsson, Niklas
    Stenke, Leif
    Hoglund, Martin
    Sandin, Fredrik
    Bjorkholm, Magnus
    Dreimane, Arta
    Lambe, Mats
    Markevarn, Berit
    Olsson-Stromberg, Ulla
    Richter, Johan
    Wadenvik, Hans
    Wallvik, Jonas
    Sjalander, Anders
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (05) : 683 - 688
12345